These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 21740748)
1. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells. Liang W; Wang XF Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748 [TBL] [Abstract][Full Text] [Related]
2. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins]. Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917 [TBL] [Abstract][Full Text] [Related]
3. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma]. Gao J; Chen M; Peng ML; Ren H Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555 [TBL] [Abstract][Full Text] [Related]
4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]. Tan G; Wang ZY; Yin S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530 [TBL] [Abstract][Full Text] [Related]
6. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
7. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
8. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells]. Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108 [TBL] [Abstract][Full Text] [Related]
9. Effects of cytotoxic T lymphocytes on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro. Wang JX; Liu GH; Fan YZ; Liu QL; Zhou J; Zhang DY; Qi YM Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):422-7. PubMed ID: 16911943 [TBL] [Abstract][Full Text] [Related]
10. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells]. Li CD; Zhang WY; Yuan CL; Han LY Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro. Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038 [TBL] [Abstract][Full Text] [Related]
12. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells. Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. Liu Y; Huang H; Chen Z; Zong L; Xiang J J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636 [TBL] [Abstract][Full Text] [Related]
15. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo. Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185 [TBL] [Abstract][Full Text] [Related]
16. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395 [TBL] [Abstract][Full Text] [Related]
17. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells]. Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818 [TBL] [Abstract][Full Text] [Related]
18. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy. Onaitis MW; Kalady MF; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333 [TBL] [Abstract][Full Text] [Related]
19. [Primary study on fusions of ovarian carcinoma cells to dendritic cell transfected with interleukin-12 gene in vitro]. Peng P; Shen K; He W; Wu M; Wei W; Lang JH; Zhang SM; Qi J; Hu Y; Zhao JQ Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):57-61. PubMed ID: 16635331 [TBL] [Abstract][Full Text] [Related]
20. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]